In an article posted in this column a few weeks ago, mesothelioma cancer lawyer it was reported that researchers at Madison-based Quintessence Bioscience were waiting for the results of a Phase IIIb clinical trial from Alfacell Corp., a significant East Coast competitor, on an anti-cancer therapeutic compound, Onconase. QBI-139, Quintessence's lead drug candidate, is very similar to Onconase but has not yet gone through clinical testing. - 6/6/08
Dr. Paul Sugarbaker, renowned oncologic surgeon specializing in mesothelioma at the Washington Cancer Institute, developed a leading-edge surgical procedure to treat mesothelioma called heated intraoperative intraperitoneal chemotherapy. - 4/29/08
The only known cause of peritoneal mesothelioma is exposure to asbestos, a mineral commonly used in fire retardant and insulating materials. The asbestos fibers may find their way into the abdomen by being swallowed or by migrating from the lungs.
Peritoneal mesothelioma can be either benign or malignant. A diagnosis of malignant peritoneal mesothelioma (abdominal cancer) is very serious. Historically, there was a less than two year average survival for patients diagnosed with malignant peritoneal mesothelioma. With modern surgical and chemotherapy treatments that have become available in recent years, however, the outlook is gradually improving. The preferred chemotherapy regimen for mesothelioma involves treatment with Alimta and Cisplatin. Surgical "debulking" of the abdominal tumor tissue may also be an option. We believe it is important to consult with a doctor knowledgeable about the latest advances in the treatment of mesothelioma to ensure the best chance of long-term survival.
If you or a loved one has been diagnosed with malignant peritoneal will arrange to fly to your home anywhere in the United States within a few days. In most cases, you will not have to travel or even appear in court. We will thoroughly investigate your case and take video depositions. You will not have to pay any attorneys' fees unless we obtain a financial settlement.
Malignant mesothelioma is an asbestos-related cancer that is difficult to accurately diagnose and is unresponsive to many therapies. It occurs in the pleura, or lining of the lung, and, in very rare cases, in other areas of the body as well. While malignant mesothelioma remains an uncommon cancer, its documented three-fold increase in males between 1970-1984 can be traced to environmental and occupational exposure.
Asbestos products, which were used primarily for insulation and heat retardation, have been banned in construction since 1975. Asbestos still presents a danger to anyone doing maintenance, repair, or demolition work in buildings containing asbestos. Mesothelioma is difficult to diagnose and even harder to treat; patients often suffer from a great deal of pain and face a poor treatment outcome.
These symptoms can also have other origins. But if you have worked with asbestos and have any of these symptoms, you should see your doctor immediately. Fleming & Associates believes anyone who has developed mesothelioma subsequent to asbestos exposure should have their case evaluated.
Mesotheliomais a disease that is almost 100% preventable; the only known cause is via exposure to the deadly mineralAsbestos. It comes from inhaling the particles of dust as theasbestosdegrades; eating away at the lining of your lungs and developing into a deadly cancer.
The Oregon Mesothelioma Help Center is not designed to provide medical advice and is intended to be for educational use only. The information provided through the Oregon Mesothelioma Help Center is not a substitute for professional care and should not be used for diagnosing or treating a health problem or a disease. If you have, or suspect you may have, a health problem we can refer you to a mesothelioma doctor or lawyer in Oregon.